Fig. 5. Nutlin-3 treatment rescues the proliferation and differentiation of NPCs in vitro. Nutlin-3 treatment rescues the proliferation and differentiation.

Slides:

Advertisements

Similar presentations

FMRP suppresses dendritic Arc protein levels.

Advertisements

Fig. 1. TP is highly expressed in myeloma.

Fig. 2. Effects of AZD4785 on proliferation and MAPK pathway signaling in KRAS mutant and wild-type cancer cells in vitro. Effects of AZD4785 on proliferation.

Fig. 1. FMRP deficiency leads to increased NSC activation in the adult dentate gyrus. FMRP deficiency leads to increased NSC activation in the adult dentate.

Differentiation of AZD4785 from MAPK pathway inhibitors in vitro

Fig. 1. Potent and selective down-regulation of KRAS mRNA and protein by AZD4785 in vitro and in vivo. Potent and selective down-regulation of KRAS mRNA.

Fig. 3. Cytokines trigger proliferation and block differentiation of perivascular adipocytes. Cytokines trigger proliferation and block differentiation.

Transfer of miR-223 during neutrophil-epithelial cell interactions

Fig. 4. Intramuscular injection of AAV9-Cas9/sgRNA-51 corrects dystrophin expression. Intramuscular injection of AAV9-Cas9/sgRNA-51 corrects dystrophin.

BET inhibition and depletion repress the expression of BRCA1 and RAD51

Fig. 6. C3 deficiency resulted in partial sparing of neuron loss in hippocampal CA3 in 16-month-old APP/PS1 mice. C3 deficiency resulted in partial sparing.

Fig. 2. Mechanism of PD-L1 down-regulation in NOD HSPCs.

β-ARs signal cooperatively with mutant EGFR and inactivate LKB1

Fig. 1. APP/PS1;C3 KO mice show improved cognitive flexibility (reversal) compared to APP/PS1 mice at 16 months of age. APP/PS1;C3 KO mice show improved.

Fig. 1. BCAS1 expression identifies newly generated oligodendrocytes.

Fig. 4. Biomechanical properties of treated tibiae.

Analysis of brain and spinal cord of treated Gaa−/− mice and controls

Fig. 3. BET inhibition reduces homologous recombination.

Fig. 6 Bimodal treatment results in reduced tinnitus loudness and reduced TFI scores in human patients. Bimodal treatment results in reduced tinnitus loudness.

Fig. 3. A circadian rhythm in fibroblast wound-healing response.

Fig. 1 MT-2 ameliorates asthmatic pulmonary resistance.

Fig. 7. The PD-L1 defect is evident in HSPCs from T1D patients.

Expression of CD36 and psap in a TMA of human ovarian cancer patients

Fig. 5. Pharmacological JAK2 inhibition in vivo abrogates tumor-initiating potential after chemotherapy. Pharmacological JAK2 inhibition in vivo abrogates.

Fig. 3. Wisper controls CF behavior and survival.

Fig. 8. Therapeutic effects of the transplantation of hiPSC-EPO–producing cells on renal anemia in adenine-treated mice. Therapeutic effects of the transplantation.

Fig. 5. Vascularization of human liver seed grafts.

Fig. 3 Biological function of TG2 and the interaction with MT-2.

Fig. 7 Gel scaffold for inhibition of postsurgical recurrence of B16F10 tumors. Gel scaffold for inhibition of postsurgical recurrence of B16F10 tumors.

Fig. 2 In vitro assessment of hESC-RPE cell sheets.

Fig. 2 STED microscopy of isolated cardiomyocytes from mice treated with MP-rhodamine–loaded CaPs. STED microscopy of isolated cardiomyocytes from mice.

Fig. 1. Muscles of LAMA2 MD patients and dyW/dyW mice contain high amounts of laminin-α4 and show deficits in BM. Muscles of LAMA2 MD patients and dyW/dyW.

Fig. 4. Expression of HGF in liver ECs cooperates with NOX4 inhibition to enhance engraftment of regenerative hepatocytes. Expression of HGF in liver ECs.

Fig. 3. β-AR signaling induces IL-6 in NSCLC cells via activation of PKC and CREB. β-AR signaling induces IL-6 in NSCLC cells via activation of PKC and.

Fig. 3. Differential mPFC PV neuron activity during exploratory behaviors in CNTNAP2 KO and WT mice. Differential mPFC PV neuron activity during exploratory.

Fig. 5 Local gel scaffold for T cell memory response.

Fig. 4. Irisin protected against oxidative stress and apoptosis in IR-injured lung tissue. Irisin protected against oxidative stress and apoptosis in IR-injured.

Fig. 2 Fas controls IL-1RA–sEV secretion in murine MSCs.

Fig. 4. Loss of DLK expression is neuroprotective in the SOD1G93A mouse model of ALS. Loss of DLK expression is neuroprotective in the SOD1G93A mouse model.

Fig. 8 SQLE inhibitor terbinafine suppresses NAFLD-HCC growth in vitro and in vivo. SQLE inhibitor terbinafine suppresses NAFLD-HCC growth in vitro and.

Fig. 4 TNF-α up-regulates Fas/Fap-1 expression to promote IL-1RA–sEV release in murine MSCs. TNF-α up-regulates Fas/Fap-1 expression to promote IL-1RA–sEV.

Volume 70, Issue 5, Pages (June 2011)

Fig. 1. β-APP overexpression or exposure to inflammatory mediators induces sIBM-like pathology in cultured rat myocytes that is abrogated by arimoclomol.

Fig. 3. Morphological changes associated with glial activation were reduced in 16-month-old APP/PS1;C3 KO mice. Morphological changes associated with glial.

Fig. 4 Analysis of ISO response in vitro in neonatal cardiomyocytes.

CD facilitates RCT in vivo and promotes urinary cholesterol excretion

Bexarotene is neuroprotective in mouse and human HD neurons in vitro

Fig. 3 CSF1 is expressed in human melanoma.

Fig. 4 Spinally grafted iPSC-NPCs show long-term survival and neuronal and glial differentiation in syngeneic recipient in the absence of immunosuppression.

Fig. 5 BRD0705 induces differentiation in AML cell lines and primary patient samples through GSK3α-selective inhibition. BRD0705 induces differentiation.

Fig. 1 LB100 and LB102 specifically inhibit PP2A phosphatase activity and the growth of BCR-ABL+ cells. LB100 and LB102 specifically inhibit PP2A phosphatase.

Fig. 4 ALRN-6924 inhibits cellular proliferation and clonogenic capacity, and induces cell cycle arrest and apoptosis in AML cell lines. ALRN-6924 inhibits.

The effects of KY19382 on chondrocyte proliferation and differentiation. The effects of KY19382 on chondrocyte proliferation and differentiation. (A) ATDC5.

UCN‐01 inhibits human IPF lung fibroblast pathological phenotypes and attenuates lung fibrosis induced by bleomycin injury UCN‐01 inhibits human IPF lung.

Effect of Z-FA-FMK on the expression of SMN proteins in SMA patient iPSCs and iPSC-derived motor neurons. Effect of Z-FA-FMK on the expression of SMN proteins.

The effect of TDP-43A315T expression at the synapse.

Fig. 4 The activation of mTOR is necessary for exercise-enhanced axonal myelination in the CC region. The activation of mTOR is necessary for exercise-enhanced.

Fig. 2. Deficiency of neuronal HS leads to reduced neuroinflammation.

Fig. 2. Acetylation stiffens primary cilia.

Fang Du, Qing Yu, Allen Chen, Doris Chen, Shirley ShiDu Yan

SiRNA directed at Ngn1 inhibited differentiation of inner ear stem cells to β-III tubulin-positive cells. a, Inner ear stem cells treated with siRNA to.

Fig. 3. Morphological changes associated with glial activation were reduced in 16-month-old APP/PS1;C3 KO mice. Morphological changes associated with glial.

HDAC inhibitor induces RAG transcription in sensory neurons.

Microfluidic platform for cell phenotype and gene function analysis

Fig. 4. HERV-K env expression and injury to lower motor neurons.

Fig. 3. HERV-K–induced neuronal toxicity in vivo.

Fig. 5 C9orf72 knockdown disrupts autophagy induction.

miR can promote cardiomyocyte proliferation in the adult heart

Fig. 2 Increasing KLF17, CDH1, and LASS2 expression reduced malignant progression and promoted apoptosis of tumor cells. Increasing KLF17, CDH1, and LASS2.

Fig. 4 Systemic AAV9 delivery of gene editing components to ΔEx44 mice rescues dystrophin expression. Systemic AAV9 delivery of gene editing components.

Presentation transcript:

Fig. 5. Nutlin-3 treatment rescues the proliferation and differentiation of NPCs in vitro. Nutlin-3 treatment rescues the proliferation and differentiation of NPCs in vitro. (A) Schematic showing that Nutlin-3 may inhibit the interaction between p-MDM2(Ser166/Ser186) and P53, relieving the repression of P53 and rescuing the proliferation and neuronal differentiation of NPCs. (B to E) Western blot analyses of p-MDM2 (B and C) and P53 (D and E) in Fmr1 WT and KO NPCs treated with Nutlin-3 (Nt3), showing that Nutlin-3 had no significant effect on p-MDM2 expression in Fmr1 KO and WT NPCs but specifically rescued P53 expression in Fmr1 KO NPCs without affecting WT cells (n = 3). GAPDH was used as a loading control in Western blot analyses. (F and G) Nutlin-3 treatment rescued the cell proliferation phenotype of Fmr1 KO NPCs, as demonstrated by immunostaining cells using the cell proliferation marker BrdU (F, red; scale bar, 20 μm), followed by quantitative analysis of BrdU+ cells (G) (n = 3). (H and I) Nutlin-3 treatment rescued neuronal differentiation phenotypes of Fmr1 KO NPCs, as assessed by a neuronal marker Tuj1+ (red; scale bar, 20 μm) (H); quantitative analysis in (I) (n = 3). (J and K) Nutlin-3 treatment specifically rescued astroglial differentiation phenotypes of Fmr1 KO NPCs, as assessed using the astroglial marker GFAP+ (green; scale bar, 20 μm) (J); quantitative analysis in (K) (n = 3). **P < 0.01; ***P < 0.001. One-way ANOVA was used for all data analyses. Data are presented as means ± SEM. Yue Li et al., Sci Transl Med 2016;8:336ra61 Published by AAAS